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¤¤
¤¤
¤ Background: Peritonitis is the leading cause of tech-
nique failure in peritoneal dialysis (PD) patients. Some
patients experience recurrent ascites, encapsulating peri-
toneal sclerosis (EPS), and even death after catheter re-
moval. Little is known, however, about the risk factors for
such complications.
¤¤
¤¤
¤ Methods: The study subjects were 117 patients that had
their PD catheter removed due to peritonitis between Janu-
ary 2000 and June 2006. Biochemical and clinical data were
reviewed retrospectively. Serum C-reactive protein (CRP)
and blood and effluent white blood cell counts (WBC) were
measured at baseline and at 72 hours of peritonitis. Based
on adverse outcomes, patients were classified into 4 groups:
non-complication (NC; n = 73), recurrent ascites (A; n = 26),
EPS (E; n = 10), and death directly related to peritonitis
(D; n = 8).
¤¤
¤¤
¤ Results: Age at PD catheter removal was significantly
higher in D group compared to NC group (62.0 ± 10.6 vs 51.2 ±
11.5 years, p < 0.05). In addition, mean PD duration was sig-
nificantly longer in E group compared to NC and A groups
(130.5 ± 48.1 vs 58.8 ± 42.4 vs 74.8 ± 47.4 months, p < 0.01).
Compared to baseline, effluent WBC was significantly de-
creased in NC group after 72 hours of peritonitis. In addi-
tion, serum CRP level was significantly decreased in NC and
A groups, whereas it was significantly increased in D group.
Multivariate analyses adjusted for age, PD duration, blood
and effluent WBC, serum CRP, and micro-organisms revealed
that serum CRP level at 72 hours predicted significantly the
development of EPS [odds ratio (OR) 1.15, p < 0.05] and peri-
tonitis-related death (OR 1.18, p < 0.01). In addition, PD
duration (per 1 month increase: OR 1.03, p < 0.05) and age
at PD catheter removal (per 1 year increase: OR 1.11, p < 0.05)
were identified as significant determinants of EPS and peri-
tonitis-related death respectively. Only effluent WBC at
72 hours was significantly associated with the development
of ascites (OR 1.27, p < 0.05).
¤¤
¤¤
¤ Conclusion: Older patients with long PD duration and
those with persistently elevated serum CRP levels were likely
to develop complications after peritonitis-related technique
failure. Our study suggests that serial measurement of CRP
may be helpful in predicting the development of complica-
tions after PD catheter removal.
Perit Dial Int 2008; 28:352–360 www.PDIConnect.com
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complications.
Peritoneal dialysis (PD) is an established treatmentmodality in end-stage renal disease patients; ap-
proximately 150 000 patients are being maintained on
continuous ambulatory PD worldwide (1). However, the
USRDS and other groups reported significantly lower
technique survival in PD patients compared to hemodi-
alysis (HD) patients, whereas overall patient survival was
reported as not different between the two treatment mo-
dalities (2–4). The main reason for the lower technique
survival with PD is peritonitis, although the incidence
of peritonitis has decreased significantly since the in-
troduction of the Y-set system (5,6). For peritonitis re-
fractory to adequate antibiotic treatment, the PD
ORIGINAL ARTICLES
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tration failure, abdominal surgery, kidney transplanta-
tion, and death not related to peritonitis, were excluded.
Demographic and clinical data were collected based
on retrospective review of patients’ records: gender, age,
primary renal disease, duration of dialysis, age at the
start of PD and at PD catheter removal, total peritonitis
episodes, duration of hospitalization, time to catheter
removal, and complications such as recurrent ascites,
EPS, and death. The following laboratory data were ob-
tained from tests done at the diagnosis of peritonitis
(baseline) and at 72 hours after start of treatment: white
blood cell counts (WBC), hematocrit, BUN, creatinine,
albumin, cholesterol, calcium, phosphorus, ferritin, and
C-reactive protein (CRP). Data for peritoneal equilibra-
tion test and Kt/V urea, which were measured within
3 months before the onset of peritonitis, were also col-
lected. In addition, causative micro-organisms and ef-
fluent WBC at the onset and at 72 hours of peritonitis
were examined. Adverse outcomes were defined as re-
current ascites, EPS, and peritonitis-related death that
developed within 90 days after PD catheter removal. Re-
current ascites was defined if paracentesis was required
more than three times to resolve ascites. Paracentesis
was conducted when symptoms of bowel compression,
such as abdominal discomfort or respiratory difficulty,
were evident and were not relieved spontaneously. All
these patients had no evidence of EPS on ultrasonogra-
phy or abdominal computed tomographic (CT) scans. Di-
agnosis of EPS was made based on clinical symptoms,
such as nausea, vomiting, and abdominal discomfort,
and CT scan findings, such as peritoneal thickening,
bowel dilation, air–fluid level, loculated ascites, and in-
creased mesenteric fat density (10,11). Peritonitis-
related death was def ined as death caused by PD
peritonitis-induced sepsis. There was no death caused
by a secondary peritonitis such as bowel perforation. All
peritonitis-related deaths occurred within 60 days of PD
catheter removal (1.4 ± 0.6 months). Additionally,
5 deaths were noted among 10 patients that developed
EPS within a median follow-up duration of 24 months.
These patients were not included in the death group be-
cause all patients with EPS survived over 90 days.
STATISTICAL ANALYSIS
Statistical analysis was performed using SPSS soft-
ware, version 13.0 (SPSS Inc., Chicago, Illinois, USA) for
Windows operating system (Microsoft Corp., Redmond,
Washington, USA). All data are expressed as mean ± SD.
To compare the differences between the complication
groups and the non-complication group, ANOVA tests
were used for continuous variables and chi-square tests
catheter should be removed. While many patients do well
without complications, leading to uneventful transfer to
HD after PD catheter removal, some patients suffer from
complications such as recurrent ascites, encapsulating
peritoneal sclerosis (EPS), and peritonitis-related death.
Therapeutic options for EPS are very limited. Inten-
sive treatment with immunosuppression, tamoxifen,
enterolysis, etc. with diverse outcomes has been reported
(7). Although EPS confers poor prognosis, with a mor-
tality rate as high as 40%, early diagnosis and treatment
may improve survival. Patients diagnosed with EPS after
cessation of PD therapy frequently present with recur-
rent ascites. Ascites due to acute inflammation can be
resolved quickly, but not in cases of severe and chronic
changes to the peritoneal membrane. Therefore, early
identification of those patients that are likely to experi-
ence postoperative problems would be of significant
clinical value. However, little is known about pertinent
clinical and laboratory data that can predict adverse
outcomes after PD catheter removal following refractory
peritonitis. Therefore, we undertook this study to inves-
tigate risk factors for developing short-term complica-
tions following peritonitis-related technique failure.
PATIENTS AND METHODS
PATIENT SELECTION AND DATA COLLECTION
This was a single-center study with retrospective data
collection. Study subjects were 117 PD patients that un-
dertook PD catheter removal due to peritonitis that did
not respond to standard antimicrobial treatment from
January 2000 to June 2006. International Society for
Peritoneal Dialysis (ISPD) committee guidelines for di-
agnostic criteria and management of PD peritonitis, in-
cluding the criteria for catheter removal, were followed
(8,9). The initial regimen was first-generation cepha-
losporin combined with aminoglycoside, which was then
changed to other antibiotics according to the sensitiv-
ity test results. Culture-negative peritonitis not respond-
ing to the initial treatment was treated with vancomycin,
third-generation cephalosporin, and an aminoglycoside.
Fungal peritonitis was managed by immediate catheter
removal followed by subsequent intravenous amphoteri-
cin-B therapy for 3 weeks. For peritonitis refractory to
adequate antibiotic treatment, the PD catheter was re-
moved and the patients switched to HD. Antibiotic treat-
ment was provided for more than 2 weeks following PD
catheter removal.
Patients with PD duration less than 3 months and age
less than 18 years were excluded. Also, patients that had
other reasons for PD catheter removal, such as ultrafil-
 at Y
O
N
SEI U
N
IV
ERSITY
 M
ED
ICA
L LIBRA
RY
 on O
ctober 28, 2014
http://w
w
w
.pdiconnect.com
/
D
ow
nloaded from
 
354
MOON et al. JULY 2008 – VOL. 28, NO. 4 PDI
were used for categorical variables. Multivariate logis-
tic regression analyses were performed to determine risk
factors for each adverse outcome after PD catheter re-
moval. Factors with p value less than 0.10 on univariate
analyses were subjected to multivariate analyses. All
probabilities were two-tailed and the level of significance
was set at 0.05.
RESULTS
DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF PATIENTS
Of the 117 patients, 65 were men and mean age at PD
catheter removal was 53.0 ± 11.8 years. Mean PD dura-
tion was 71.6 ± 48.9 (range 3 – 185) months and mean
follow-up duration after PD catheter removal was 28.6 ±
22.7 months. A total of 348 peritonitis episodes occurred
and overall peritonitis rate of these 117 patients was
0.82 episodes/patient-year. The most common cause of
end-stage renal disease was diabetes mellitus nephrop-
athy (n = 30, 25.6%), followed by chronic glomerulone-
phritis (n = 29, 24.8%) and hypertension (n = 15, 12.8%).
Patients were classified into four groups according to
adverse outcomes that developed following PD catheter
removal: non-complication (NC; n = 73), recurrent as-
cites (A; n = 26), EPS (E; n = 10), and death directly re-
lated to PD peritonitis (D; n = 8).
COMPARISON OF CLINICAL CHARACTERISTICS AND
BIOCHEMICAL DATA AMONG THE FOUR GROUPS
Table 1 presents the differences in clinical character-
istics and biochemical data among the four groups. There
were no differences in age at the start of PD, total peri-
tonitis episodes, Kt/V urea, or dialysate-to-plasma creat-
inine ratio at 4 hours among the four groups. However,
age at PD catheter removal was significantly higher in
D group compared to NC group (62.0 ± 10.6 vs 51.2 ± 11.5
years, p < 0.05). In addition, mean PD duration was sig-
nificantly longer in E group compared to NC and A groups
(130.5 ± 48.1 vs 58.8 ± 42.4 vs 74.8 ± 47.4 months, p <
0.01). Time to PD catheter removal was not different
among the four groups. Among biochemical data mea-
sured at 72 hours of peritonitis, serum cholesterol level
was significantly higher in NC group compared to A and
D groups (142.5 ± 38.2 vs 118.6 ± 34.1 vs 104.1 ±
27.2 mg/dL, p < 0.05). In addition, serum albumin level
was lower in D group compared to NC group but did not
reach statistical significance (Table 1).
Table 2 and Figures 1 and 2 show serial changes in
blood and effluent WBC and serum CRP levels among the
four groups. Baseline serum CRP level was significantly
higher in E group compared to NC group. Subsequent
follow-up of this parameter after 72 hours of peritonitis
revealed that E and D groups had significantly higher CRP
levels compared to NC and A groups. In addition, efflu-
ent WBC at 72 hours was significantly lower in NC group
than in the other three groups, and blood WBC at
72 hours was significantly higher in E group compared
to NC group (Table 2). Compared to baseline, effluent
WBC was signif icantly decreased in NC group after
72 hours of peritonitis. However, it was not significantly
decreased in A group and it showed an increasing trend
in E and D groups without statistical significance (Table 2
and Figure 1). In addition, serum CRP level was signifi-
cantly decreased in NC and A groups, whereas it remained
persistently elevated in E group and was even more in-
creased in D group (Table 2 and Figure 2). When serum
CRP level was monitored beyond 72 hours, it continu-
ously decreased to normal in NC group, whereas it de-
creased slowly over a longer period in A group (data not
shown).
COMPARISON OF MICRO-ORGANISMS AMONG THE FOUR
GROUPS
Causative micro-organisms are provided in Table 3.
Culture-negative peritonitis rates were relatively higher
(30.1%) in NC group compared to A, E, and D groups. Over-
all, micro-organisms were not significantly different
among the four groups. However, NC group had a trend
toward a lower rate of gram-negative bacteria or fungal
peritonitis that did not reach statistical significance.
MULTIVARIATE ANALYSES OF RISK FACTORS FOR ADVERSE
OUTCOMES
Multivariate logistic regression analyses were per-
formed separately to assess the risk factors of each ad-
verse outcome (i.e., recurrent ascites, EPS, and death)
after PD catheter removal (Table 4). Variables with
p value less than 0.10 on univariate analyses were ad-
justed for multivariate analyses, and these included age
at PD catheter removal, PD duration, effluent WBC at
72 hours, and serum CRP level at 72 hours. Blood WBC at
72 hours was considered only in the analysis for EPS, and
micro-organisms (gram negative and fungus vs not) only
for recurrent ascites and death. For EPS, serum CRP level
at 72 hours [odds ratio (OR) 1.15, p < 0.05] and PD dura-
tion (per 1 month increase: OR 1.03, p < 0.05) were sig-
nif icant predictors for the development of EPS. In
addition, serum CRP level at 72 hours (OR 1.18, p < 0.01)
and age at PD catheter removal (per 1 year increase: OR
1.11, p < 0.05) were identified as significant determi-
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nants of peritonitis-related death. On the other hand,
only effluent WBC at 72 hours was significantly associ-
ated with development of ascites (OR 1.27, p < 0.05).
None of the baseline parameters was an independent
predictor of complications after PD catheter removal.
DISCUSSION
Although there have been studies aimed at identify-
ing risk factors for PD peritonitis (12,13), as well as risk
factors associated with catheter removal following acute
peritonitis episodes (14), studies specifically aimed at
evaluating pertinent clinical and laboratory data that
can predict adverse outcomes after PD catheter removal
following refractory peritonitis have not been reported
yet. In the present study, 44 patients (representing 38%
of 117 patients that required catheter removal) devel-
oped various complications postoperatively, which
caused them considerable morbidity and mortality,
whereas the remainder had an uneventful transition into
HD. Early identification of patients likely to develop com-
plications post-catheter removal would be of consider-
able clinical value.
The major finding of this study was that persistently
elevated serum CRP level was a significant determinant
of both EPS and peritonitis-related death after PD cath-
eter removal. In addition, long-term PD duration and old
age were independently associated with high risk of EPS
and peritonitis-related death, respectively, following
technique failure due to peritonitis. No baseline param-
eters were independent predictors of complications, al-
though baseline CRP level was significantly higher in
E group compared to NC group.
C-reactive protein is a marker of inflammation and an
elevated serum level is associated with increased risk of
mortality and morbidity in end-stage renal disease pa-
tients (15–17). A recent study by Zalunardo et al. showed
that higher serum CRP at baseline and at the third week
after diagnosis predicted short- and long-term adverse
outcomes respectively in PD-associated peritonitis (18).
Patients with higher CRP levels at diagnosis had greater
odds of adverse short-term outcomes, such as switch to
TABLE 1
Comparison of Clinical Characteristics and Biochemical Data Among Four Groups of Peritoneal Dialysis (PD) Patients
Non-complication Recurrent ascites EPS Death
Patients (n) 73 26 10 8
Gender (male/female) 41/32 15/11 5/5 4/4
Age at PD start (years) 46.4±12.2 47.3±12.6 46.9±10.8 53.5±10.6
Age at PD removal (years) 51.2±11.5 54.6±11.8 55.2±12.6 62.0±10.6b
Duration of PD (months) 58.8±42.4 (55) 74.8±47.4 (66) 130.5±48.1a,c (133) 88.9±29.3 (75)
Diabetes mellitus 19 (26.0%) 6 (23.1%) 2 (20%) 3 (37.5%)
Cardiovascular comorbidity 13 (17.8%) 4 (15.4%) 1 (5%) 2 (25.0%)
Time to PD catheter removal (days) 5.0±1.1 4.9±0.9 4.7±1.0 4.5±0.8
Hospital days 21.8±17.2 (18) 41.4±20.9a (38) 45.5±24.0a (43) 45.6±26.2a (39)
Peritonitis (total n episodes) 2.88±2.20 2.77±1.68 2.50±1.65 2.81±1.87
Peritonitis rate (episodes/patient-year) 0.98±1.08 0.55±0.50 0.56±0.94 0.50±0.45
Kt/V urea 1.93±0.50 1.93±0.52 2.23±0.24 1.91±0.20
PET (D/P Cr at 4 hours) 0.73±0.27 0.68±0.12 0.75±0.15 0.69±0.19
Hematocrit (%) 30.5±3.7 28.6±5.0 27.6±3.9 28.1±2.0
Calcium (mg/dL) 8.8±0.9 8.6±0.8 8.4±1.2 8.8±0.6
Phosphorus (mg/dL) 4.4±1.3 3.9±1.4 4.0±1.2 3.5±1.9
BUN (mg/dL) 44.9±13.9 44.2±20.1 46.0±16.1 39.7±20.1
Creatinine (mg/dL) 10.0±3.6 9.7±3.6 9.9±2.5 8.2±2.9
Total cholesterol (mg/dL) 142.5±38.2 118.6±34.1b 119.6±37.0 104.1±27.2b
Serum albumin (g/dL) 2.6±0.5 2.4±0.4 2.6±0.6 2.2±0.3
Ferritin (mg/dL) 325.5±269.3 733.5±673.7a 951.5±529.3a 698.9±583.8
PET = peritoneal equilibration test; D/P Cr = dialysate-to-plasma ratio of creatinine; EPS = encapsulating peritoneal sclerosis.
a p < 0.01 versus non-complication group.
b p < 0.05 versus non-complication group.
c p < 0.01 versus ascites group.
All data are expressed as mean±SD. Median values are presented in parentheses for PD duration and hospital days. Laboratory
data were measured at 72 hours of peritonitis.
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HD, death, persistent infection beyond planned therapy
duration, and relapse. Highlighting the importance of
serum CRP level, these results are in line with the present
study, although we particularly focused on the outcomes
of patients that underwent PD catheter removal due to
peritonitis. Our data showed that elevated serum CRP
level could be a useful marker for predicting EPS and
mortality after PD catheter removal. To the best of our
knowledge, there has been no report suggesting that
elevated CRP level is a significant predictor of the devel-
opment of EPS, although it is commonly increased in the
acute stage of EPS (11). Of note, baseline CRP level was
TABLE 2
Serial Changes in Blood and Effluent White Blood Cell Counts (WBC) and Serum C-Reactive
Protein (CRP) Levels Between Baseline and 72 Hours of Peritonitis
Group Blood WBC (/mm3) Effluent WBC (/mm3) Serum CRP (mg/dL)
Non-complication Baseline 9693±5111 2413±3513 12.2±11.5
At 72 hr 9058±4220 1292±1662b 7.8±7.5b
Recurrent ascites Baseline 10066±6791 3684±3192 16.3±8.2
At 72 hr 9617±7498 2793±2139a 11.1±4.6c
EPS Baseline 12428±8606 3332±3335 23.4±11.3a
At 72 hr 15005±8156a 4107±3601a 23.9±11.5a,d
Death Baseline 9606±4761 2525±2142 17.4±6.0
At 72 hr 12 800±4326 3266±1655a 24.2±7.9a,b,d
EPS = encapsulating peritoneal sclerosis.
a p < 0.01 versus non-complication group.
b p < 0.01 versus baseline.
c p < 0.05 versus baseline.
d p < 0.01 versus ascites group.
Figure 1 — Changes in effluent white blood cell count (WBC) between baseline and 72 hours of peritonitis. Effluent WBC at 72 hours
was significantly decreased compared to baseline in the non-complication group. A = non-complication group; B = ascites group;
C = encapsulating peritoneal sclerosis group; D = death group. *p < 0.01 versus baseline.
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not a significant determinant of adverse outcomes in the
multivariate analyses (for EPS: OR 1.06, p = 0.334; for
death: OR 0.92, p = 0.162). This finding suggests that
serial measurement of this parameter rather than a
single measurement might be a valuable tool for moni-
toring the eff icacy of antibiotic treatment and for
TABLE 3
Comparison of Micro-Organisms Among Four Groups
Non-complication Recurrent ascites EPS Death
Gram positive 24 (32.9%) 9 (34.6%) 2 (20%) 2 (25%)
MSSA 11 6 2 2
MRSA 6 1 0 0
MRCoNS 4 0 0 0
Others 3 2 0 0
Gram negative 17 (23.3%) 10 (38.4%) 2 (20%) 4 (50%)
Pseudomonas species 7 5 0 1
Escherichia coli 3 4 1 1
Others 7 1 1 2
Fungus and tuberculosis 10 (13.7%) 4 (15.4%) 3 (30%) 2 (25%)
Candida species 7 3 2 2
Tuberculosis 3 1 1 0
No growth 22 (30.1%) 3 (11.5%) 3 (30%) 0 (0%)
Total 73 (100%) 26 (100%) 10 (100%) 8 (100%)
MSSA = methicillin-sensitive Staphylococcus aureus; MRSA = methicillin-resistant Staphylococcus aureus; MRCoNS = methicillin-
resistant coagulase-negative staphylococcus; EPS = encapsulating peritoneal sclerosis.
Figure 2 — Changes in serum C-reactive protein (CRP) levels between baseline and 72 hours of peritonitis. Serum CRP level was
significantly decreased compared to baseline in the non-complication group and the ascites group, whereas it was significantly
increased in the death group. A = non-complication group; B = ascites group; C = encapsulating peritoneal sclerosis group; D =
death group. *p < 0.01 versus baseline; †p < 0.05 versus baseline.
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predicting adverse outcomes. Relevant to our results are
the earlier report by Hind et al. that the height of CRP
response correlated well with the severity and extent of
peritoneal damage (19). They found that patients that
recovered uneventfully after antimicrobial treatment
showed a prompt fall in CRP from its peak value within
48 hours of the start of antimicrobial treatment, whereas
each patient in whom the serum CRP value remained
raised after treatment had a complicated course.
Factors implicated in the etiology of EPS are long-term
PD duration, recurrent peritonitis, bioincompatible PD
solution, chlorhexidine, beta-blocker use, etc. (10). Our
study also revealed that PD duration was a significant
determinant of EPS developing after peritonitis-related
catheter removal. Long-term exposure to glucose-based
bioincompatible PD fluid may alter the normal immuno-
logic reactions against bacteria (18,20,21). Fibrin de-
posits, collagen accumulation, and decreases in the
viability and number of peritoneal macrophages may all
contribute to decreased per itoneal host defense
(21–23). Considering these deleterious effects, long-
term PD patients are more likely to develop severe peri-
tonitis, which often requires catheter removal, and are
at increased risk of developing complications postopera-
tively, such as EPS and mortality. In this regard, EPS
might be an ongoing complication of long-term PD (first
hit), with the second hit being the peritonitis, resulting
in fulminant EPS as suggested by Honda and Oda (24).
Earlier reports implicated PD duration as an impor-
tant predictor of outcome following bacterial peritoni-
tis, such as nonresolution [defined as death due to
peritonitis, catheter removal, or transfer to HD (25)] and
peritonitis-related mortality (26). In the present study,
PD duration was not an independent risk factor for peri-
tonitis-related death, although PD duration was longer
in the D group compared to the NC group. This differ-
ence could be due to the relatively small number of pa-
tients in the  D group (n = 8). A recent study also reported
that PD duration was not predictive of outcome includ-
ing mortality (18). In accordance with a recent report
(26), increased age was also a significant risk factor for
peritonitis-related death in this study. However, other
reports found no significant association between age and
peritonitis-associated outcomes (17,25).
In the present study, only effluent WBC at 72 hours
was significantly associated with the development of
ascites. Although serum CRP level was more elevated and
gradually decreased over a longer period compared to
TABLE 4
Multivariate Logistic Regression Analyses for Adverse Outcomes After
Peritoneal Dialysis (PD) Peritonitis-Related Technique Failure
Odds ratio (95% CI) p Value
Recurrent ascitesa
PD duration (per 1 month increase) 1.00 (0.99–1.01) 0.696
Effluent WBC (per 1000/mm3 increase)b 1.27 (1.02–1.60) 0.045
Serum CRP (per 1 mg/dL increase)b 0.94 (0.87–1.05) 0.361
Age at catheter removal (per 1 year increase) 1.01 (0.97–1.06) 0.624
Gram(–) or fungus (yes vs no) 2.90 (0.45–11.05) 0.245
Encapsulating peritoneal sclerosisc
PD duration (per 1 month increase) 1.03 (1.01–1.06) 0.021
Blood WBC (per 1000/mm3 increase)b 1.07 (0.90–1.26) 0.446
Effluent WBC (per 1000/mm3 increase)b 1.10 (0.75–1.62) 0.633
Serum CRP (per 1 mg/dL increase)b 1.15 (1.02–1.28) 0.020
Age at catheter removal (per 1 year increase) 1.01 (0.92–1.10) 0.874
Peritonitis-related deatha
PD duration (per 1 month increase) 0.99 (0.97–1.01) 0.443
Effluent WBC (per 1000/mm3 increase)b 1.16 (0.77–1.74) 0.470
Serum CRP (per 1 mg/dL increase)b 1.18 (1.06–1.32) 0.004
Age at catheter removal (per 1 year increase) 1.11 (1.01–1.22) 0.041
Gram(–) or fungus (yes vs no) 1.16 (0.16–8.19) 0.884
WBC = white blood cell count; CRP = C-reactive protein; CI = confidence interval.
a Adjusted for age, PD duration, effluent WBC, serum CRP level, and micro-organisms (gram negative or fungus vs not).
b These parameters were measured at 72 hours of peritonitis.
c Adjusted for age, PD duration, blood and effluent WBC, and serum CRP level.
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NC group, it was not a significant determinant of the
development of ascites. This finding implies that severe
peritoneal inflammation might contribute to this com-
plication and that systemic inflammation was less severe
in this population. Ascites after PD catheter removal
could be induced by persistent peritonitis-related in-
flammation. Some mediators such as endothelial nitric
oxide synthase and vascular endothelial growth factor
might contribute to the development of ascites (27,28).
Ascites developing after catheter removal could also be
caused by inadequate volume and uremic control during
HD treatment. However, this is very unlikely since these
patients were carefully monitored for volume control with
periodic chest x ray and more frequent HD. On the other
hand, development of ascites could be a process of EPS
(11). Twenty-six patients that presented recurrent as-
cites in our study did not show typical signs or symptoms
and typical findings of EPS on ultrasonography or CT
scan. Ascites spontaneously resolved in most patients
during follow-up; however, careful attention should be
paid to these patients and in monitoring the develop-
ment of EPS.
There are several limitations in this study. This was a
retrospective study with a small number of patients. The
small numbers of patients in E and D groups might have
led to inadequate statistical power. For example, neither
gram-negative bacteria nor fungal peritonitis was a sig-
nificant predictor of death, despite a higher rate of these
micro-organisms in D group compared to NC group. An
earlier report identified the etiologic agent as a defi-
nite marker of peritonitis-related mortality, with fungal
and enteric peritonitis being associated with higher
mortality (26). The relatively higher rate of culture-nega-
tive peritonitis (30.1% in NC group) is another weakness.
This may have influenced the potential role of bacterial
etiologic agents as a risk factor. It is possible that ster-
ile peritonitis induced by icodextrin might be involved
in the high rate of culture-negative peritonitis in NC
group. However, this is very unlikely because most pa-
tients in this group responded well to antimicrobial treat-
ment and only 4 patients used icodextrin. Malnourished
PD patients are more likely to develop postoperative com-
plications such as prolonged infection and peritonitis-
related mortality (26,29). In our study, D group might
have been more malnourished, as indicated by their
lower cholesterol levels. Serum albumin level was lower
in D group although this was not statistically significant.
Serum cholesterol level was not an independent risk fac-
tor for death in this study (data not shown). Unfortu-
nately, nutritional assessments utilizing Subjective
Global Assessment or anthropometric measurements
were not performed at baseline or during treatment.
In conclusion, the present study revealed that per-
sistently elevated serum CRP level, older age, and long
PD duration are significant predictors of adverse out-
comes in PD patients after peritonitis-related catheter
removal. Our study suggests that serial measurements
of serum CRP during the course of peritonitis may be
helpful in earlier identification of individuals at greater
risk of developing complications following PD catheter
removal.
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